Drug Pricing Reform: Latest Healthcare Policy Updates
Healthcare & Life Sciences: Drug Pricing Digest — Number 69
Our Drug Pricing and Market Access team tracks recent developments in healthcare reform, the Medicaid Drug Rebate Program, the 340B Program, Medicare, and state law.
The Drug Pricing and Market Access team monitors evolving healthcare legislation affecting the Medicaid Drug Rebate Program, 340B Program, and Medicare. Recent developments in drug pricing reform and state-level healthcare laws continue reshaping market access strategies. These regulatory changes significantly impact pharmaceutical pricing and patient affordability nationwide.
Original Article
Read full article on HomeExplore More
Related News
MAHA and science-based public health: Can’t we all just get along? | Science-Based Medicine
Science-Based Medicine · 2026.04.15
Health Sciences Weekend Unites Alumni Around Shared Health Science Center Story - UTHSC News
UTHSC News · 2026.04.14
Molecular Sciences Building - Premier Construction
ROMA Publications Ltd · 2026.04.14
Monmouth College Enhances Computer Science Program
River Cities’ Reader · 2026.04.14
Designing Winners - College of Arts and Sciences
College of Arts and Sciences · 2026.04.14
The 9 Best Science Podcasts
2026.04.14